Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market: Industry Analysis and Forecast (2024-2030)

  • Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market size was valued at US$ 289.87 Mn. in 2023 and the total revenue is expected to grow at 5.6% 

  • Format : PDF | Report ID : SMR_772

Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market Definition/Overview:

Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market is projected to grow with a significant growth rate during the forecast period (2024-2030). Following political turmoil in Arab countries, a considerable focus has grown on the Middle East and Africa's lack of adequate healthcare. The healthcare system in many Gulf Cooperation Council (GCC) countries, and a major portion of North Africa is still underdeveloped. The African Union (AU) members, using the United Nations 2030 Development Agenda and specifically SDG 3 (Good Health and Wellbeing) concerning healthcare, have pledged to try and achieve universal health coverage by 2030. The AU has also launched a health financing initiative in 2019, pledging up to $200 million to help end epidemics and bring universal health coverage to all. The market for Endoscopic Retrograde Cholangiopancreatography is projected to be hampered by high operation costs. The Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market is likely to benefit from an increase in the launch of innovative products and the development of teleoperated surgical operating systems.

 

Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market

 

To get more Insights: Request Free Sample Report

 

Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market Dynamics:

The middle east and Africa market is projected to grow significantly during the forecast period (2024-2030) owing to solid investment in the healthcare sector by the constituent countries. Another factor that drives the Endoscopic Retrograde Cholangiopancreatography forward is the increasing population of aged people. This is an important indicator of growth because ageing population is the major segment of patients that undergo ailments requiring diagnosis via Endoscopic Retrograde Cholangiopancreatography. Gallstones, inflammatory strictures (scars), leaks (after trauma and surgery), and cancer are all disorders that Endoscopic Retrograde Cholangiopancreatography is used to identify and treat. To determine the source of jaundice, upper abdominal pain, or unexplained weight loss, an ERCP may be required.

 

According to a report from World Health Organization, chronic diseases such as heart disease and renal failure will become the leading causes of mortality in Sub-Saharan Africa by 2030, accounting for 42 percent of all deaths in the region. This factor will raise the Endoscopic Retrograde Cholangiopancreatography market since chronic diseases are expected to rise in the near future, resulting in an increase in surgical treatments, which will drive the market upwards. Furthermore, the existence of good medical tourism and international corporations has attracted many investors to invest in this region, particularly the United Arab Emirates and Saudi Arabia, which will enhance the industry during the forecast period.

 

Moreover, increasing investment by the Middle East and African countries on healthcare and hospital infrastructure is driving the market forward. Aging population, longer life expectancies, and sedentary lifestyles, which lead to an increase in obesity, cancer, and diabetes, are all driving forces of Endoscopic Retrograde Cholangiopancreatography. New modes of care and out-of-hospital services are emerging as a result of an emphasis on prevention and well-being rather than just treatment. Saudi Arabia, for example, is constructing a new healthcare system that includes primary, community, and secondary care. Many of the oil-rich GCC states had not invested in new public healthcare infrastructure since the mid-80s. In the past five years, most GCC governments are spending to meet demands for growing healthcare services. Amidst these heavy increases in capital expenditures and healthcare costs, the important aspect is what measures do these GCC countries take to ensure proper quality control on their indigenous healthcare systems. As the basic microeconomic premise suggests, increased quantity does not necessarily mean increased quality.

In Africa, there has been an increase in the prevalence of common gastrointestinal (GI) conditions such as diarrhoea. As a result, the landscape of GI sickness is shifting to chronic illness morbidity and mortality. Endoscopic services are in high demand in Africa because to the rise in chronic gastrointestinal disorders such as non-infectious gastric ulcer disease, malignancy, dyspepsia, and cirrhosis. Increasing patient desire for minimally invasive procedures, high rates of chronic diseases, improved awareness, and technical improvements are all contributing to the market's current expansion. Endoscopic operations that are minimally invasive include benefits such as less pain, faster recovery, small incisions, less blood loss, and cost savings. As a result of the enhanced quality of care, the market for Endoscopic Retrograde Cholangiopancreatography in Africa is growing.

 

Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis:

On the basis of product type, imaging devices are projected to dominate the market by 2030 due to growth of epidemics in the African region owing to which the people of the resident countries have started to prefer minimally invasive surgeries. Colorectal cancer is very common in African women, according to the World Health Organization. Furthermore, the rate of occurrence per 100,000 people is roughly 8.2 percent. As a result, colonoscopy is becoming increasingly common in the area. Furthermore, the overall expansion of the market researched is predicted to be driven by increased technological advancements in colonoscopy technologies and an increase in the population suffering from colorectal malignancies. Tumours, colon polyps, ulcers, and inflammatory or bleeding portions of the lower digestive area are all identified using imaging device in respective type of physical examinations. There is a high rate of colorectal cancer in South Africa which is driving the imaging devices segment upwards.

 

Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market

 

On the basis of end user, the Endoscopic Retrograde Cholangiopancreatography Market in Middle East and Africa is dominated by hospitals and clinics as governments of constituent countries are focussing heavily on building healthcare infrastructure and providing clinical aid to the residents in order to tackle large spread endemics and lifestyle related issues common and very specific to the middle east and African region. The increased assistance from governments through expenditures to further grow the scale of home healthcare services, even in rural areas, is primarily to achieve the market growth potential of Endoscopic Retrograde Cholangiopancreatography. Furthermore, rising disposable income in metropolitan regions has a considerable impact on regional market demand. Growing inclination for tailored treatment at home privately is also a factor fuelling the size of the Endoscopic Retrograde Cholangiopancreatography market. People are now aware of imaging and endoscopic testing devices, which is expected to increase demand in the market.

 

On the basis of application, Biliary Stenting is projected to dominate the Endoscopic Retrograde Cholangiopancreatography Market due to increase in medical diagnosis that require stenting in the Middle East and Africa region. Within the non-vascular stents industry, the pancreatic and biliary stents market is projected to grow at a significant rate. An increase in endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) operations are driving the market growth. Moreover, medical experts have started prescribing higher percentage of procedures requiring stenting and recurring stenting, Overall, the market for fully covered metal pancreatic and biliary stents is growing at the fastest pace, whereas the market for non-covered metal pancreatic and biliary stents is shrinking in the Middle East and Africa region.   

 

The objective of the report is to present a comprehensive analysis of the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market to the stakeholders in the industry. The report pr0ovides trends that are most dominant in the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market and how these trends will influence new business investments and market development throughout the forecast period. The report also aids in the comprehension of the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market dynamics and competitive structure of the market by analyzing market leaders, market followers, and regional players.

 

The qualitative and quantitative data provided in the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market report is to help understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas, which will drive the industry and market growth through the forecast period. The report also includes the competitive landscape of key players in the industry along with their recent developments in the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market. The report studies factors such as company size, market share, market growth, revenue, production volume, and profits of the key players in the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market.

 

The report provides Porter's Five Force Model, which helps in designing the business strategies in the market. The report helps in identifying how many rivals are existing, who they are, and how their product quality is in the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market. The report also analyses if the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market is easy for a new player to gain a foothold in the market, do they enter or exit the market regularly if the market is dominated by a few players, etc.

 

The report also includes a PESTEL Analysis, which aids in the development of company strategies. Political variables help in figuring out how much a government can influence the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market. Economic variables aid in the analysis of economic performance drivers that have an impact on the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market. Understanding the impact of the surrounding environment and the influence of environmental concerns on the Middle East and Africa Endoscopic Retrograde Cholangiopancreatography market is aided by legal factors.

 

Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market Scope:

Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market

Market Size in 2023

USD 289.87 Mn.

Market Size in 2030

USD 424.47 Mn.

CAGR (2024-2030)

5.6 Percent

Historic Data

2018-2022

Base Year

2023

Forecast Period

2024-2030

Segment Scope

by Product Type

  • Endoscopes
  • Endotherapy Devices
  • Imaging Devices
  • Energy Devices

by Application

  • Biliary Sphincterotomy
  • Biliary Dilatation
  • Biliary Stenting
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Dilatation
  • Pancreatic Duct Stenting

by End-User

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

Country Scope

South Africa
GCC
Egypt
Nigeria
Rest of the Middle East and Africa

 

Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Key Players:  

  • FUJIFILM Healthcare UAE (UAE)
  • Olympus MEA (Egypt)
  • Pentax Medical EMEA (Hamburg)
  • Ethicon EMEA(UAE)   
  • KARL STORZ ENDOSKOPE East Mediterranean & Gulf (UAE)
  • Boston Scientific Middle East FZ-LLC (UAE)
  • Medtronic Africa (Africa)
  • Smith+Nephew USD Ltd (Saudi Arabia)
  • Steris Middle East (UAE)
  • Richard Wolf Middle East (UAE)


Frequently Asked Questions

Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market revenue is expected to grow at 5.6 % through 2024 to 2030.

  1. Scope of the Report
  2. Research Methodology
    • Research Process
    • Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market: Target Audience
    • Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market: Primary Research (As per Client Requirement)
    • Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market: Secondary Research
  3. Executive Summary
  4. Competitive Landscape
    • Stellar Competition matrix
    • Key Players Benchmarking: by Product, Pricing, Investments, Expansion Plans, Physical Presence, and Presence in the Market.
    • Mergers and Acquisitions in Industry: M&A by Region, Value, and Strategic Intent
    • Market Dynamics
      • Market Drivers
      • Market Restraints
      • Market Opportunities
      • Market Challenges
      • PESTLE Analysis
      • PORTERS Five Force Analysis
      • Value Chain Analysis
  5. Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market Segmentation
    • Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market, by Product Type (2023-2030)
      • Endoscopes
      • Endotherapy Devices
      • Imaging Devices
      • Energy Devices
    • Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market, by Application (2023-2030)
      • Biliary Sphincterotomy
      • Biliary Dilatation
      • Biliary Stenting
      • Pancreatic Sphincterotomy
      • Pancreatic Duct Dilatation
      • Pancreatic Duct Stenting
    • Middle East and Africa Endoscopic Retrograde Cholangiopancreatography Market, by End-User (2023-2030)
      • Hospitals & Clinics
      • Ambulatory Surgery Centers
      • Others
  6. Company Profiles
    • Key Players
      • FUJIFILM Healthcare UAE (UAE)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Business Strategy
        • Key Developments
      • Olympus MEA (Egypt)
      • Pentax Medical EMEA (Hamburg)
      • Ethicon EMEA(UAE)       
      • KARL STORZ ENDOSKOPE East Mediterranean & Gulf (UAE)
      • Boston Scientific Middle East FZ-LLC (UAE)
      • Medtronic Africa (Africa)
      • Smith+Nephew USD Ltd (Saudi Arabia)
      • Steris Middle East (UAE)
      • Richard Wolf Middle East (UAE)
  7. Key Findings
  8. Recommendations

Enquiry Before Buy


Request Sample PDF